New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 4720 | Entacapone | Potent COMT inhibitor; blocks α-synuclein aggregation |
| 4709 | RuBi GABA trimethylphosphine | Caged GABA; inhibits neural activity |
| 4675 | CCT 031374 hydrobromide | Inhibits TCF-dependent transcription; lowers β-catenin levels |
| 4640 | N,N-Dimethylsphingosine | Sphingosine kinase inhibitor |
| 4575 | TC HSD 21 | Potent and selective 17β-hydroxysteroid dehydrogenase type 3 inhibitor |
| 4465 | TCS ERK 11e | Potent and selective ERK2 inhibitor |
| 4409 | SR 1664 | High affinity PPARγ ligand; blocks Cdk5-dependent PPARγ phosphorylation |
| 4386 | TC-P 262 | Selective P2X3, P2X2/3 antagonist |
| 4054 | PEP 005 | Protein kinase C activator |
| 0923 | SR 141716A | Selective CB1 receptor antagonist |